Feb. 10, 2020

20. Hair dye and breast cancer commentary - Basosquamous cell carcinomas are BCCs with ARID1a mutations - Dupilumab for kids under 12 - Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS - Nado

20. Hair dye and breast cancer commentary - Basosquamous cell carcinomas are BCCs with ARID1a mutations - Dupilumab for kids under 12 - Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS - Nado
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon
Season 1
  • Hair dye and breast cancer commentary -
  • Basosquamous cell carcinomas are BCCs with ARID1a mutations -
  • Dupilumab for kids under 12 -
  • Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS -
  • Nadolol-induced death in infantile hemangioma -
  • Dermasphere clip show - episodes 11-20!